Comprehensive Analysis of Missense Variations in the BRCT Domain of BRCA1 by Structural and Functional Assays
- 14 June 2010
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 70 (12), 4880-4890
- https://doi.org/10.1158/0008-5472.can-09-4563
Abstract
Genetic screening of the breast and ovarian cancer susceptibility gene BRCA1 has uncovered a large number of variants of uncertain clinical significance. Here, we use biochemical and cell-based transcriptional assays to assess the structural and functional defects associated with a large set of 117 distinct BRCA1 missense variants within the essential BRCT domain of the BRCA1 protein that have been documented in individuals with a family history of breast or ovarian cancer. In the first method, we used limited proteolysis to assess the protein folding stability of each of the mutants compared with the wild-type. In the second method, we used a phosphopeptide pull-down assay to assess the ability of each of the variants to specifically interact with a peptide containing a pSer-X-X-Phe motif, a known functional target of the BRCA1 BRCT domain. Finally, we used transcriptional assays to assess the ability of each BRCT variant to act as a transcriptional activation domain in human cells. Through a correlation of the assay results with available family history and clinical data, we define limits to predict the disease risk associated with each variant. Forty-two of the variants show little effect on function and are likely to represent variants with little or no clinical significance; 50 display a clear functional effect and are likely to represent pathogenic variants; and the remaining 25 variants display intermediate activities. The excellent agreement between the structure/function effects of these mutations and available clinical data supports the notion that functional and structure information can be useful in the development of models to assess cancer risk. Cancer Res; 70(12); 4880–90. ©2010 AACR.This publication has 53 references indexed in Scilit:
- Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test resultsHuman Mutation, 2008
- Functional assays for BRCA1 and BRCA2The International Journal of Biochemistry & Cell Biology, 2007
- Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?Breast Cancer Research, 2007
- A Systematic Genetic Assessment of 1,433 Sequence Variants of Unknown Clinical Significance in the BRCA1 and BRCA2 Breast Cancer–Predisposition GenesAmerican Journal of Human Genetics, 2007
- Abraxas and RAP80 Form a BRCA1 Protein Complex Required for the DNA Damage ResponseScience, 2007
- Functional Impact of Missense Variants in BRCA1 Predicted by Supervised LearningPLoS Computational Biology, 2007
- Determination of Cancer Risk Associated with Germ Line BRCA1 Missense Variants by Functional AnalysisCancer Research, 2007
- Structural Basis for Cell Cycle Checkpoint Control by the BRCA1−CtIP Complex,Biochemistry, 2005
- Improved Splice Site Detection in GenieJournal of Computational Biology, 1997
- Identification of a RING protein that can interact in vivo with the BRCA1 gene productNature Genetics, 1996